Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation.
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D003523:Cycloserine / Q000008:administration & dosage; D004977:Ethambutol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D009161:Mycobacterium / Q000187:drug effects; D009164:Mycobacterium Infections / Q000188:drug therapy; D014376:Tuberculosis / Q000188:drug therapy; D014785:Vision, Ocular / Q000187:drug effects*
D000995:Antitubercular Agents; D004977:Ethambutol; D003523:Cycloserine